Zydus LifesciencesNSE: ZYDUSLIFEBSE: 532321Healthcare · PharmaceuticalsZydus Lifesciences Corporate Actions
Zydus Lifesciences has declared 1 bonus issue and 1 stock split. The most recent was dated 06 Oct 2015.
- Bonus Issue
- 1
- Stock Split
- 1
- Dividends
- 13
Zydus Lifesciences bonus issue history
Every bonus issue Zydus Lifesciences has declared, newest first.
| Ex Date | Type | Particulars |
|---|---|---|
| bonus | Bonus issue 1:1 |
Zydus Lifesciences stock split history
Every stock split Zydus Lifesciences has declared, newest first.
| Ex Date | Type | Particulars |
|---|---|---|
| split | Stock Split From Rs.5/- to Rs.1/- |
Zydus Lifesciences dividends
Zydus Lifesciences has declared 13 dividends, most recently ₹1 per share with an ex-date of 24 Jul 2026.
How this is calculated
Corporate actions are sourced from company filings with NSE and BSE. Ex-date is the first day the stock trades without entitlement. Only actions the company has formally declared appear here.
Index membership reflects the Nifty 100 as published by NSE Indices, effective 2026-03-30.
Zydus Lifesciences: frequently asked questions
Has Zydus Lifesciences announced a bonus issue?
Zydus Lifesciences has declared 1 bonus issue, the most recent with an ex-date of 30 Aug 2006.
Has Zydus Lifesciences announced a stock split?
Zydus Lifesciences has declared 1 stock split, the most recent with an ex-date of 06 Oct 2015.
How many dividends has Zydus Lifesciences declared?
Zydus Lifesciences has 13 declared dividends on record, the latest being ₹1 per share with an ex-date of 24 Jul 2026.
What is a corporate action?
A corporate action is any company-initiated event that affects its shares — a dividend, bonus issue, stock split, rights issue, buyback or merger. Each one is declared to the exchanges with an ex-date.
What is the difference between a bonus issue and a stock split?
A bonus issue creates new shares out of reserves and hands them to existing holders free, so paid-up capital rises. A stock split subdivides existing shares into a smaller face value, leaving capital unchanged. Both increase the share count and reduce the price proportionally.
More Zydus Lifesciences data
Compare corporate actions with peers
Comparing corporate actions across companies is more useful than reading one in isolation — the peer links above open the same view for Zydus Lifesciences’s closest listed competitors.
The data, ratios and commentary about Zydus Lifesciences Ltd (ZYDUSLIFE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.